ProEncia Biotechnology
PrivateLast Round
Pre Seed
May 19, 2026
Total Funding Raised
$1.51M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ProEncia Biotechnology operates in Healthcare & Life Sciences and is based in Saint Paul, Minnesota. Its latest recorded funding round was a Pre Seed round in May 2026.
ProEncia Biotechnology is a biotechnology company developing a new generation of non-invasive oral care options for adult patients at all stages of periodontal disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ProEncia Biotechnology Comparables
Compare ProEncia Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PerioTrap Pharmaceuticals GmbH | 79% | |
| Nordicus Partners Corporation | 79% | |
| Oral Biolife Inc. | 78% |
For institutional investors. Book with your work email.
ProEncia Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | May 19, 2026 | ||||
| Seed Round | Oct 4, 2024 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2026
Completed a Pre Seed funding round.
- Oct 4, 2024
$1.51M seed round raised.
For institutional investors. Book with your work email.
ProEncia Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ProEncia Biotechnology's valuation, stock price, and market status.
Is ProEncia Biotechnology a public or private company?
ProEncia Biotechnology is a private company.
What is the current stock price of ProEncia Biotechnology?
ProEncia Biotechnology is a private company, so its shares have no public market price. Caplight tracks ProEncia Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ProEncia Biotechnology worth (valuation)?
Valuation information for ProEncia Biotechnology is not publicly available.
Can I buy ProEncia Biotechnology stock?
ProEncia Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ProEncia Biotechnology's last funding round?
ProEncia Biotechnology's most recent funding round was Pre Seed on May 19, 2026.
Who are the main investors in ProEncia Biotechnology?
Investor information for ProEncia Biotechnology is not publicly disclosed.
Will ProEncia Biotechnology IPO soon?
No public IPO plans have been announced for ProEncia Biotechnology.
How can I track ProEncia Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades in ProEncia Biotechnology's shares on secondary markets.